Samil Pharmaceutical (000520.KS) Earnings Analysis
Samil Pharmaceutical (000520.KS) has no confirmed upcoming earnings date. Trailing P/E -3.86.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 000520.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 000520.KS. This page updates as the calendar is published.
000520.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-12-30 | -521.74519 KRW | n/a | n/a | n/a |
| 2025-06-30 | -306.25258 KRW | n/a | n/a | n/a |
| 2025-05-15 | -427.99887 KRW | n/a | n/a | n/a |
| 2025-02-03 | -181.65393 KRW | n/a | n/a | n/a |
| 2024-11-14 | -40.90504 KRW | n/a | n/a | n/a |
| 2024-08-14 | 21.19 KRW | n/a | n/a | n/a |
000520.KS valuation and analyst view
| Trailing P/E | -3.86 |
|---|---|
| Trailing EPS | -1,707.71933 KRW |
| Price / book | 1.09 |
| Dividend yield | 0.00% |
| Market cap | 133.99B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Samil Pharmaceutical (000520.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 000520.KS. This page updates as the calendar is published.
Did 000520.KS beat earnings last quarter?
Consensus estimate data was not available for 000520.KS's 2025-12-30 report.
What is 000520.KS's current P/E ratio and EPS?
000520.KS trades at a trailing P/E of -3.86 on trailing EPS of -1707.7193270992905 KRW.
What do analysts rate 000520.KS?
000520.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.